Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select... see more

TSX:GUD - Post Discussion

Knight Therapeutics Inc > Isn’t this down another 50% since September report?
View:
Post by wofats on Jan 28, 2022 2:54pm

Isn’t this down another 50% since September report?

 

This is down again since last reporting period . 

Won't it show up as another mm loss or has the position been lessened or terminated?


Singular Genomics Systems, Inc. (OMIC)

NasdaqGS - NasdaqGS Real Time Price. Currency 
6.60+0.52 (+8.55%)
As of 02:40PM EST. Market open.
  •  
Comment by MrMugsy on Jan 28, 2022 3:13pm
On Sept 30, 2021 it was at $11.19 On Dec 31, 2021 it was at $11.56 So ... it should appear as a slight increase in value on the next financials - if we still held at Dec 31. No idea of we kept it or sold it off.
Comment by Chianchin on Jan 30, 2022 8:58am
Re: few last posts? The Usual useless irrelevant noise as mugsy/aliases attempt to self heal the irreparable damaged ego and to cover  mugsy's/ aliases financial damaging looses. His/her wealth is down by 75% by his/her admission. 
Comment by wofats on Apr 11, 2022 9:26pm
Isn't this in play this quarter?  If yes it is another 12M loss on this investment quarter on quarter. As well On the 40M ebida are not we at 56M now? Setting the bar fairly low perhaps.
Comment by gudisgood on Apr 12, 2022 3:03am
Do you mean the current quarter or Q1? I guess it's in play for both but the Q1 unrealized loss will be around $7M (since it closed Q1 at $6.31) as per the annual report: "On May 26, 2021 Singular Genomics Systems, Inc. (“SGS”), an investment held within Domain Associated LLC (“Domain”), announced the closing of its initial public offering at a public offering price of USD 22 per share ...more  
Comment by MrMugsy on Apr 12, 2022 9:11am
A week or two back I posted on this one. For Q1, this will have a $6M-$7M loss on adjustment. Going by memory. --------------------------------- Will see if there are any gains to counter that loss - such is the financing/investment arm.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities